Volume 19, Issue 5, Pages (November 2003)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 22, Issue 4, Pages e4 (October 2017)
Volume 40, Issue 1, Pages (January 2014)
A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice by Fernando E. Sepulveda, Sophia Maschalidi,
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Feedback Regulation of Pathogen-Specific T Cell Priming
by Norman Nausch, Ioanna E
by Daniel L. Barber, Katrin D. Mayer-Barber, Lis R. V
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 34, Issue 3, Pages (March 2011)
Volume 30, Issue 4, Pages (April 2009)
Volume 9, Issue 4, Pages (October 1998)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 31, Issue 5, Pages (November 2009)
Volume 45, Issue 2, Pages (August 2016)
Volume 45, Issue 2, Pages (August 2016)
Volume 30, Issue 4, Pages (April 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 37, Issue 1, Pages (July 2012)
Volume 13, Issue 3, Pages (September 2000)
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 21, Issue 1, Pages (July 2004)
Volume 35, Issue 6, Pages (December 2011)
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells  Christian M. Schürch,
Volume 29, Issue 2, Pages (August 2008)
Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation  Isabel Barao, Maite.
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 1, Pages (July 2009)
Volume 46, Issue 6, Pages e4 (June 2017)
Volume 40, Issue 2, Pages (February 2014)
Volume 20, Issue 4, Pages (April 2004)
Volume 33, Issue 1, Pages (July 2010)
Volume 45, Issue 1, Pages (July 2016)
Volume 31, Issue 5, Pages (November 2009)
Volume 19, Issue 5, Pages (November 2003)
Volume 31, Issue 5, Pages (November 2009)
Volume 40, Issue 1, Pages (January 2014)
Volume 27, Issue 5, Pages (November 2007)
Volume 6, Issue 6, Pages (December 2009)
Volume 25, Issue 3, Pages (September 2006)
Volume 19, Issue 6, Pages (December 2003)
Volume 16, Issue 2, Pages (July 2016)
Volume 15, Issue 5, Pages (November 2001)
Volume 27, Issue 2, Pages (August 2007)
Volume 32, Issue 5, Pages (May 2010)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 38, Issue 3, Pages (March 2013)
Volume 35, Issue 2, Pages (August 2011)
Volume 18, Issue 3, Pages (March 2003)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 15, Issue 3, Pages (September 2001)
Volume 29, Issue 4, Pages (October 2008)
Volume 31, Issue 4, Pages (October 2009)
Volume 31, Issue 2, Pages (August 2009)
Volume 26, Issue 4, Pages (April 2007)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 32, Issue 1, Pages (January 2010)
Volume 7, Issue 2, Pages (August 1997)
SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8+ T Cells with Innate Lymphocyte Characteristics  Mihalis Verykokakis,
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 5, Pages (May 2008)
Volume 22, Issue 8, Pages (February 2018)
Volume 27, Issue 4, Pages (October 2007)
Volume 35, Issue 4, Pages (October 2011)
Volume 33, Issue 5, Pages (November 2010)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 2, Pages (August 2009)
Hepatic Interleukin-7 Expression Regulates T Cell Responses
Volume 13, Issue 11, Pages (December 2015)
Volume 39, Issue 2, Pages (August 2013)
Presentation transcript:

Volume 19, Issue 5, Pages 701-711 (November 2003) GATA-3 Promotes Maturation, IFN-γ Production, and Liver-Specific Homing of NK Cells  Sandrine I Samson, Odile Richard, Manuela Tavian, Thomas Ranson, Christian A.J Vosshenrich, Francesco Colucci, Jan Buer, Frank Grosveld, Isabelle Godin, James P Di Santo  Immunity  Volume 19, Issue 5, Pages 701-711 (November 2003) DOI: 10.1016/S1074-7613(03)00294-2

Figure 1 Lymphoid Reconstitution in HSC Chimeras FL-derived HSC were transferred into alymphoid mice (Rag°γc°) to generate hematopoietic chimeras. (A) Flow cytometric analysis of splenocytes stained for B (CD19+) and T (CD3+) cells. NK cells (NK1.1+ IL2Rβ+) were detected in the CD19−CD3− fraction. (B) Absolute numbers of NK cells (CD3−NK1.1+IL-2Rβ+) and B cells (CD19+) in control C57Bl/6 (black circles, n = 14) and GATA-3° (gray circles, n = 16) chimeras. The mean values are represented by a gray bar. There is a significant decrease in splenic NK cells (p = 0.04) and no difference in B cells in the absence of GATA-3. (C) Expression of IL-2Rβ, 2B4, DX5, and CD2 on splenic CD3−NK1.1+ cells was similar in control C57Bl/6 (shaded histogram) and GATA-3° (bold line) chimeras. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)

Figure 2 Natural Cytotoxicity in the Absence of GATA-3 (A) Freshly isolated splenocytes from control C57Bl/6 (black) and GATA-3° (gray) chimeras showed similar lytic activity against 51Cr-labeled YAC-1 target cells. Indicated numbers of NK cells were added per well as determined by parallel flow cytometric analysis. One representative experiment of four is shown. (B) Control C57Bl/6 (black) and GATA-3° (gray) splenocytes were stimulated for 16 hr with IL-2 alone (circles) or in combination with IL-12 (squares) prior to analysis of lytic activity against YAC-1 target cells. One representative experiment of two is shown. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)

Figure 3 GATA-3° Chimeras Fail to Control Early Listeria Infection Nonreconstituted Rag°γc° mice or CD3ϵ° or GATA-3° chimeras (groups of 4 to 5 mice) were infected intravenously with 2 × 103 colony forming units (CFU) of the L. monocytogenes strain LO29 (Bregenholt et al., 2001). (A) Serum IFN-γ levels were measured 2 days postinfection using a cytokine-specific sandwich ELISA. (B) Bacterial burden in the spleen and liver of infected mice were enumerated 4 days postinfection. One representative experiment of two is shown. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)

Figure 4 GATA-3° NK Cell Are Poor Producers of IFN-γ (A) Polarized murine Th1 and Th2 clones (stimulated with phorbol ester and ionomycin) or splenocytes from control or GATA-3° chimeras (stimulated for 16 hr with a combination of IL-2/12/18) were analyzed for intracellular IFN-γ or IL-13. For NK cells, analysis was performed on electronically gated CD3−NK1.1+ cells. One representative experiment of six is shown. (B) Splenic NK cells from control (in this case, CD3ϵ°) or GATA-3° chimeras were stimulated for 24 hr with IL-2 and IL-12, IL-18, IL-12+18 (2 × 104 cells) or with mAb against CD11b or 2B4 (104 cells) and IFN-γ release measured by ELISA. Significantly more IFN-γ was released in response to IL-12+18 compared to IL-12 alone (p < 0.05). (C) Semiquantitative PCR analysis of T-bet and Hlx expression in sorted splenic NK cells (CD3−NK1.1+IL-2Rβ+) from control or GATA-3° chimeras. Two-fold dilutions of cDNA were tested as well as HPRT levels to control for integrity and quantity of the input cDNA. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)

Figure 5 Peripheral GATA-3° NK Cells Have an Immature Phenotype (A) Expression of CD11b, CD43, and B220 on splenic CD3−IL-2RβNK1.1+ NK cells from CD3ϵ° and GATA-3° chimeras. Percentages of positive cells are indicated. (B) Expression of CD11b and CD43 on bone marrow CD3−IL-2RβNK1.1+ NK cells from CD3ϵ° and GATA-3° chimeras. Percentages of positive cells are indicated. (C) Expression of CD94, Ly49D, Ly49C/I, Ly49G2, and KLRG-1 on splenic CD3−IL-2RβNK1.1+ NK cells from CD3ϵ° and GATA-3° chimeras. Percentages of positive cells are indicated. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)

Figure 6 Selective Deficiency of Liver NK Cells in GATA-3° Chimeras (A) Absolute number of hepatic and bone marrow NK cells in control C57Bl/6 (black circles; n = 14) and GATA-3° (gray circles; n = 16) chimeras. There is a highly significant decrease in liver NK cells (p = 2.3 × 10−5) and a significant increase in BM NK cells (p = 0.002) in the absence of GATA-3. (B) Expression of indicated adhesion molecules on splenic CD3−IL-2RβNK1.1+ NK cells from control C57Bl/6 (shaded histograms) and GATA-3° (bold line) chimeras. (C) Bone marrow from CD3ϵ° and GATA-3° chimeras was labeled with CFSE and injected in Rag°γc° mice. The percentage of CD3ϵ° or GATA-3° NK cells among CFSE+ cells identified in the spleen or liver 15 hr after injection is indicated. Significantly fewer liver NK cells are recovered from GATA-3° BM transfers (p < 0.05). One representative mouse of six (for each genotype) is shown. Immunity 2003 19, 701-711DOI: (10.1016/S1074-7613(03)00294-2)